[APLS] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 1.78%
YoY- -94.11%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 -142 0 0 0 12 -
PBT -118,617 -168,822 -113,217 -69,825 -71,090 -50,574 -36,459 119.72%
Tax 6,914 3,933 3,981 540 388 340 2,383 103.55%
NP -118,617 -168,822 -113,217 -69,825 -71,090 -50,574 -36,459 119.72%
Tax Rate - - - - - - - -
Total Cost 118,617 168,822 113,075 69,825 71,090 50,574 36,471 119.67%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 79,646.45 0.00 0.00 0.00 -315,885.24 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.57 -2.29 -1.54 -1.10 -1.12 -0.87 -0.65 80.11%
EPS Diluted -1.57 -2.29 -1.54 -1.10 -1.12 -0.87 -0.63 83.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.